Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03882411 · ClinicalTrials.gov registry record · NA
An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)
A NA study of Depressive Symptoms and Coronary Heart Disease, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 361
- Enrollment target
- 1
- Study location
NCT03882411: Completed NA study of Depressive Symptoms and Coronary Heart Disease, sponsored by Columbia University.
NCT03882411 is a NA study of Depressive Symptoms and Coronary Heart Disease that has completed, run by Columbia University. The registered enrollment target is 361 participants, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03882411, a NA study of Depressive Symptoms and Coronary Heart Disease, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.
Primary Outcome
Change in total BDI (21-item measure of depressive symptoms \[0-63\]; higher score constitutes worse burden of symptoms) from baseline to follow visit during the pre-intervention period compared to post-intervention period
Conditions Studied
Interventions
- BEHAVIORAL Electronic shared decision making (eSDM) tool
Study Locations (1)
New York
- Columbia University Irving Medical Center/New York Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2019-04-23 |
| Est. Completion | 2025-04-10 |
| Phase | NA |
What the finished NCT03882411 record still lists
NCT03882411 is an interventional study that assigns participants to a tested intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap, above the 256-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (41% higher).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Electronic shared decision making (eSDM) tool is the first listed.
NCT03882411 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03882411 about?
NCT03882411 is a clinical study titled "An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)". The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.
What is the current status of trial NCT03882411?
This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2019-04-23. Estimated completion is 2025-04-10.
What conditions does trial NCT03882411 study?
This clinical trial studies the following conditions: Depressive Symptoms, Coronary Heart Disease.
What interventions are being tested in trial NCT03882411?
The interventions under investigation include: Electronic shared decision making (eSDM) tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT03882411?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03882411 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03882411's enrollment target sits among peer trials
361 7th of 60 higher than 54 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI